Sljedeći

Auto Play

Progression of Metastatic Pancreatic Cancer

6 Pogledi • 07/30/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play